A detailed history of Tower Research Capital LLC (Trc) transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,570 shares of OMGA stock, worth $3,427. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,570
Previous 12,019 61.98%
Holding current value
$3,427
Previous $24,000 79.17%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.22 - $2.25 $9,087 - $16,760
-7,449 Reduced 61.98%
4,570 $5,000
Q2 2024

Aug 13, 2024

BUY
$1.86 - $3.2 $12,804 - $22,028
6,884 Added 134.06%
12,019 $24,000
Q1 2024

May 15, 2024

BUY
$2.73 - $5.32 $2,964 - $5,777
1,086 Added 26.82%
5,135 $18,000
Q4 2023

Feb 13, 2024

SELL
$1.35 - $3.21 $1,159 - $2,757
-859 Reduced 17.5%
4,049 $12,000
Q3 2023

Nov 14, 2023

BUY
$2.15 - $5.68 $6,093 - $16,097
2,834 Added 136.64%
4,908 $10,000
Q2 2023

Aug 14, 2023

SELL
$5.6 - $9.66 $56,498 - $97,459
-10,089 Reduced 82.95%
2,074 $11,000
Q1 2023

May 09, 2023

BUY
$4.81 - $10.95 $39,494 - $89,910
8,211 Added 207.77%
12,163 $74,000
Q4 2022

Feb 10, 2023

SELL
$4.22 - $7.05 $21,146 - $35,327
-5,011 Reduced 55.91%
3,952 $23,000
Q3 2022

Nov 10, 2022

BUY
$3.63 - $6.65 $13,623 - $24,957
3,753 Added 72.03%
8,963 $49,000
Q2 2022

Aug 15, 2022

BUY
$2.01 - $7.19 $7,109 - $25,431
3,537 Added 211.42%
5,210 $19,000
Q1 2022

May 12, 2022

SELL
$6.24 - $14.04 $18,351 - $41,291
-2,941 Reduced 63.74%
1,673 $10,000
Q4 2021

Feb 14, 2022

BUY
$11.33 - $29.38 $47,971 - $124,394
4,234 Added 1114.21%
4,614 $52,000
Q3 2021

Nov 15, 2021

BUY
$16.0 - $22.51 $6,080 - $8,553
380 New
380 $7,000

Others Institutions Holding OMGA

About Omega Therapeutics, Inc.


  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $35.9M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.